In 2023, the market size value per capita for hormones in dosage, excluding contraceptives and antibiotics, in Germany, stands as a benchmark before the forecasted period from 2024 onward. Forecasts indicate a steady year-on-year increase in market size, with a notable compound annual growth rate (CAGR) of around 1.51% predicted through 2028.
Future trends to watch for include:
- Technological advancements in hormone production might influence market growth positively.
- Regulatory changes in healthcare policies concerning hormone usage.
- Potential impacts of demographic shifts and aging population affecting demand.
- Development of personalized hormone therapies possibly shaping consumer preferences.
